Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.200
-0.060 (-1.41%)
Apr 29, 2026, 10:57 AM EDT - Market open
Coya Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 |
| Cash & Equivalents | 46.82 | 38.34 | 32.63 | 5.93 | 4.34 | Upgrade
|
| Cash & Short-Term Investments | 46.82 | 38.34 | 32.63 | 5.93 | 4.34 | Upgrade
|
| Cash Growth | 22.13% | 17.51% | 449.85% | 36.72% | -50.23% | Upgrade
|
| Other Receivables | - | 0.73 | 7.5 | - | - | Upgrade
|
| Receivables | - | 0.73 | 7.5 | - | - | Upgrade
|
| Prepaid Expenses | 3.12 | 5.24 | 1.07 | 1.25 | 0.24 | Upgrade
|
| Total Current Assets | 49.94 | 44.31 | 41.2 | 7.18 | 4.58 | Upgrade
|
| Property, Plant & Equipment | 0.01 | 0.04 | 0.07 | 0.09 | 0.12 | Upgrade
|
| Long-Term Deferred Charges | - | - | - | 1.12 | 0.09 | Upgrade
|
| Total Assets | 49.95 | 44.35 | 41.26 | 8.4 | 4.79 | Upgrade
|
| Accounts Payable | 1.06 | 1.59 | 1.16 | 1.82 | 0.86 | Upgrade
|
| Accrued Expenses | 3.61 | 1.39 | 2.25 | 2.01 | 0.29 | Upgrade
|
| Current Income Taxes Payable | - | - | 0.72 | - | - | Upgrade
|
| Current Unearned Revenue | 1.2 | 0.85 | 0.92 | - | - | Upgrade
|
| Total Current Liabilities | 5.87 | 3.82 | 5.05 | 3.82 | 1.15 | Upgrade
|
| Long-Term Debt | - | - | - | 12.97 | - | Upgrade
|
| Long-Term Unearned Revenue | 1.05 | 0.95 | 0.57 | - | - | Upgrade
|
| Total Liabilities | 6.92 | 4.77 | 5.63 | 16.79 | 1.15 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Additional Paid-In Capital | 104.99 | 80.31 | 61.5 | 0.68 | 0.47 | Upgrade
|
| Retained Earnings | -61.96 | -40.74 | -25.86 | -17.87 | -5.62 | Upgrade
|
| Comprehensive Income & Other | - | - | -0.01 | - | - | Upgrade
|
| Total Common Equity | 43.03 | 39.58 | 35.64 | -17.19 | -5.15 | Upgrade
|
| Shareholders' Equity | 43.03 | 39.58 | 35.64 | -8.39 | 3.64 | Upgrade
|
| Total Liabilities & Equity | 49.95 | 44.35 | 41.26 | 8.4 | 4.79 | Upgrade
|
| Total Debt | - | - | - | 12.97 | - | Upgrade
|
| Net Cash (Debt) | 46.82 | 38.34 | 32.63 | -7.03 | 4.34 | Upgrade
|
| Net Cash Growth | 22.13% | 17.51% | - | - | -50.23% | Upgrade
|
| Net Cash Per Share | 2.80 | 2.52 | 3.21 | -2.71 | 1.68 | Upgrade
|
| Filing Date Shares Outstanding | 23.46 | 16.72 | 14.54 | 9.95 | 2.59 | Upgrade
|
| Total Common Shares Outstanding | 20.93 | 16.71 | 14.41 | 2.59 | 2.59 | Upgrade
|
| Working Capital | 44.07 | 40.48 | 36.14 | 3.36 | 3.44 | Upgrade
|
| Book Value Per Share | 2.06 | 2.37 | 2.47 | -6.64 | -1.99 | Upgrade
|
| Tangible Book Value | 43.03 | 39.58 | 35.64 | -17.19 | -5.15 | Upgrade
|
| Tangible Book Value Per Share | 2.06 | 2.37 | 2.47 | -6.64 | -1.99 | Upgrade
|
| Machinery | - | - | 0.14 | 0.14 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.